HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Clayer Selected Research

Mark Clayer Research Topics

Disease

3Osteosarcoma (Osteogenic Sarcoma)
04/2015 - 06/2002
3Neoplasms (Cancer)
07/2008 - 06/2002
1Bursitis (Adhesive Capsulitis)
11/2014
1Arthritis (Polyarthritis)
11/2014
1Infections
11/2010
1Chondrosarcoma
09/2009
1Aneurysmal Bone Cysts
05/2008
1Melanoma (Melanoma, Malignant)
08/2002
1Breast Neoplasms (Breast Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

1Antirheumatic Agents (DMARD)IBA
11/2014
1Calcium Sulfate (Alabaster)IBA
05/2008
1Messenger RNA (mRNA)IBA
08/2002
1Ephrin-B3 (Ephrin B3)IBA
08/2002
1LigandsIBA
08/2002
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2002
1Proteins (Proteins, Gene)FDA Link
08/2002
1Ephrin-A5 (AL-1)IBA
08/2002
1Ephrin-B1 (Ephrin B1)IBA
08/2002
1Ephrin-B2 (Ephrin B2)IBA
08/2002
1EphA1 Receptor (Eph Receptor)IBA
08/2002
1EphrinsIBA
08/2002
1Ephrin-A1 (Ephrin A1)IBA
08/2002
1Ephrin-A3 (Ephrin A3)IBA
08/2002
1Ephrin-A4 (Ephrin A4)IBA
08/2002
1CytokinesIBA
06/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2002

Therapy/Procedure

1Neoadjuvant Therapy
04/2015
1Reoperation
11/2010
1Surgical Amputation (Amputations)
09/2009
1Limb Salvage
07/2008
1Injections
05/2008
1Therapeutics
06/2002
1Drug Therapy (Chemotherapy)
06/2002